Compare these too: Cloverleaf Bio, Inc. · Praeventix, Inc. · Episteme Prognostics, Inc. · Episteme Prognostics, Inc. · Polyrizon Ltd.
← The full Tempo Therapeutics, Inc. record · every deck on file · all funding signals
Against the 15 raises on file in Biotechnology. Median $5.60M, largest $78.80M.
How does your raise compare?
Enter an amount to place it against the filings on record.
Percentiles are drawn from the 1403 Form D filings held here that state an amount, filed between 3 and 11 September 2026 — 1371 of them in the 19 industry groups large enough to rank against (5 filings minimum).
| Rank | Company | Score | Raise size | Filed | People named | Investors in | Form D cadence | Filing history |
|---|---|---|---|---|---|---|---|---|
| 1 | Cloverleaf Bio, Inc.leads | 72 | $14.80M · 64th pctadds 25 | 2026-09-09 · 3d agoadds 23 | 5adds 12 | 12adds 12 | not stated | not stated |
| 1 | Tempo Therapeutics, Inc.this pageleads | 72 | $14M · 57th pctadds 22 | 2026-09-11 · 1d agoadds 23 | 5adds 12 | 43adds 15 | not stated | not stated |
| 3 | Praeventix, Inc. | 63 | $5.60M · 50th pctadds 20 | 2026-09-10 · 2d agoadds 23 | 4adds 12 | 9adds 8 | not stated | not stated |
| 4 | Episteme Prognostics, Inc. | 62 | $5.09M · 36th pctadds 14 | 2026-09-04 · 8d agoadds 23 | 4adds 13 | 22adds 12 | 6not scored | 6 since 2022not scored |
| 4 | Episteme Prognostics, Inc. | 62 | $5.09M · 36th pctadds 14 | 2026-09-04 · 8d agoadds 23 | 3adds 13 | 14adds 12 | 6not scored | 6 since 2022not scored |
| 6 | Polyrizon Ltd. | 57 | $4M · 29th pctadds 11 | 2026-09-10 · 2d agoadds 23 | 9adds 18 | 1adds 5 | not stated | not stated |
A score out of 100 comparing what each company's record shows for raise size within its industry group, filing recency, people named on the filing and investors disclosed.
- Raise size within its industry groupup to 39
- Filing recencyup to 23
- People named on the filingup to 23
- Investors disclosedup to 15
- Form D cadence and filing history depthshown, not scored
- 75 and up
- 55 to 74
- 35 to 54
- under 35
| Company | On the record | Industry group | Filed |
|---|---|---|---|
| Cloverleaf Bio, Inc. | $14.80M | Biotechnology | 2026-09-09 |
| Praeventix, Inc. | $5.60M | Biotechnology | 2026-09-10 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Polyrizon Ltd. | $4M | Biotechnology | 2026-09-10 |
| BioLineRx Ltd. | $3.75M | Biotechnology | 2026-09-09 |
| Pluri Inc. | $3.68M | Biotechnology | 2026-09-04 |
| Gossamer Bio, Inc. | $25M | Biotechnology | 2026-09-04 |
| Therapeutic Neuromodulation Systems LLC | $970K | Biotechnology | 2026-09-11 |
| Amplica Bio, Inc. | $30K | Biotechnology | 2026-09-11 |
| Airway Therapeutics, Inc. | $43.50M | Biotechnology | 2026-09-09 |
| Superluminal Medicines, Inc. | $65.48M | Biotechnology | 2026-09-03 |
| Iambic Therapeutics, Inc. | $65.97M | Biotechnology | 2026-09-09 |
| ALZHEON, INC. | $78.80M | Biotechnology | 2026-09-10 |
| Tempo Therapeutics, Inc. (this page) | $14M | Biotechnology | 2026-09-11 |
14 other records here are in this industry group.
How this list is chosen
Nearest by stated offering size, inside the industry group the filing itself declares (Biotechnology). Nothing is inferred about what a company does.